hims & hers semaglutide makes deal with Novo in obesity strategy shift Hims & Hers Health will

10.3390/jcm14113791 23 RodriguezP

Xia X, Liu H, Lv H, Zhang J, Zhou J, Zhao Z

Lilly insisted there was no more shortage, and the FDA eventually agreed

adults were living with obesity in 2024, clinical guidelines began recommending GLP-1 initiation within six months of diagnosis rather than after lifestyle failure

We invite you to download our free weight loss ebook, packed with insights into: How peptides like GLP-1 work What hormone imbalances may be sabotaging your results Tips for building lasting habits around nutrition and fitness Questions to ask before starting any medical weight loss plan This free resource will help you make informed decisions and understand the steps you can take to finally take control of your health and your weight

Szaefer, Hanna, et al